First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.
Narayan R, Piérola AA, Donnellan WB, Yordi AM, Abdul-Hay M, Platzbecker U, Subklewe M, Kadia TM, Alonso-Domínguez JM, McCloskey J, Bradford K, Curtis M, Daskalakis N, Guttke C, Safer K, Hiebert B, Murphy J, Li X, Duchin K, Esteban D.
Narayan R, et al.
Clin Transl Sci. 2024 Mar;17(3):e13742. doi: 10.1111/cts.13742.
Clin Transl Sci. 2024.
PMID: 38494922
Free PMC article.
Clinical Trial.